secwatch.observer — SEC 8-K summary
======================================

Issuer:     Adicet Bio, Inc. (ACET)
CIK:        0001720580
Form:       8-K
Filed at:   2021-11-18T23:59:59+00:00
Accession:  0000950170-21-004750
Event type: leadership
Sentiment:  positive
Materiality: 0.45
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Adicet Bio appoints Dr. Michael Kauffman to board of directors
--------------------------------------------------------------

- Appointed Michael Kauffman, M.D., Ph.D. to Board, effective Nov 17, 2021.
- Dr. Kauffman is independent and will serve on the Nominating and Corporate Governance Committee.
- Received option to purchase 37,000 shares at $9.39, vesting over 36 months.
- Over 20 years industry experience; co-founder and former CEO of Karyopharm; led Velcade development.
- Fills vacancy; board now includes three NCG committee members.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1720580/000095017021004750/0000950170-21-004750-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1720580/000095017021004750/acet-20211117.htm
  HTML page:      https://secwatch.observer/filing/0000950170-21-004750

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer